A Study of TY-302 in Patients With Advanced Solid Tumors
NCT04433494
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
60
Enrollment
INDUSTRY
Sponsor class
Conditions
Breast Cancer
Solid Tumor
Interventions
DRUG:
TY-302: capsule, 25mg/50mg ; Tamoxifen: tablet,10mg
Sponsor
TYK Medicines, Inc